Skip Ribbon Commands
Skip to main content
Sign In

Pages :pUse SHIFT+ENTER to open the menu (new window).Open MenuOpen Menu
This system library was created by the Publishing feature to store pages that are created in this site.

  
  
  
Synonyms, Keywords
Test Components
22726PCPacked Red Blood Cells
Packed Cells, Leukoreduced Red Cells, LRBC, RBC, PRBC​
ABO/RH, ABSC, CROSSMATCH​
24709PCS10Pain Clinic Drugs with Confirmation
​Amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, methadone, opiates, oxycodone, buprenorphine, Clonazepam, Temazepam, Diazepam, Chlordiazepoxide, Alprazolam, Flunitrazepam, Flurazepam, Nordiazepam, Chlorazepate, Marijuana, THC, Benzoylecgonine, Cocaine, Hydromorphone, Hydrocodone, Morphine, Codeine, Oxymorphone, Oxycodone, Oxycontin, Vicodin, Amines
​Immunoassay screen with quantitative confirmation by liquid chromatography methods (when needed) for the following drug classes or method groups:  amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, opiate method group, oxycodone method group, and buprenorphine.  Test also includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.
 
Immunoassay screen for ethanol with quantitative result.
 
The immunoassay screening test for the Benzodiazepines drug class does not detect Lorazepam or Clonazepam well.  If either of these drugs are suspected, please order the test “Benzodiazepines, Urine, Confirm Only by LC/MSMS” in addition to this test to insure detection if present.
24726PCS10WOPain Clinic Drugs without Confirmation
​amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, methadone, opiates, oxycodone, buprenorphine
​Immunoassay screen for the following drug classes or method groups:  amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, ethanol, methadone, opiate method group, oxycodone, and buprenorphine.  Test also includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.
 
The immunoassay screening test for the Benzodiazepines drug class does not detect Lorazepam or Clonazepam well.  If either of these drugs are suspected, please order the test “Benzodiazepines, Urine, Confirm Only by LC/MSMS” in addition to this test to insure detection if present.
26153PCS4WOPain Clinic Survey 4 Without Confirmation, Urine
​Drug screen, drug test, barbiturates, cannabinoids, marijuana, THC, cocaine, ethanol

Immunoassay screen for the following drug classes or method groups: barbiturates, cannabinoids, cocaine, and ethanol. Test also includes specimen validity testing (creatinine) to detect adulteration, dilution, or substitution of the specimen.

Results of this test are presumptive. If confirmatory testing is desired, the confirmatory test(s) can be ordered as add-on (u-have) tests, utilizing the original urine collection, within 9 days of the original test.

This test is intended to compliment the test “Targeted Drug Panel, Urine” (TDPU).

24932PE1SOPancreatic Elastase, Fecal (123234)
​​PE1​, Elactase, Pancreatic, ST PE1SO, Pancreatic Elastase, Fecal (1232​34)
24817HPPSOPancreatic Polypeptide, Plasma (HPP)
​HPP (Human Pancreatic Polypeptide), Human Pancreatic Polypeptide, PP (Pancreatic Polypeptide,Plasma)
26386PANEXSOPanorama Extended Panel

​​​​Trisomy 21, Trisomy 18Trisomy 13Monosomy XTriploidy, 22q11.2 Deletion, 1p36 DeletionCri-du-chat SyndromePrader-Willi Syndrome Angelman syndromeChromosome abnormalities, Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome, Klinefelter Syndrome, Triple X Syndrome, Jacob's Syndrome

​The Panorama Extended Panel includes the screening that is offered by the Panorama Prenatal Panel (Trisomy 21, Trisomy 18, Trisomy 13, Monosomy X and Triploidy), as well as additional screening for microdeletion conditions including 22q11.2 deletion syndrome, 1p36 deletion, Cri-du-chat syndrome, Prader-Willi syndrome and Angelman syndrome.

26385PANORSOPanorama Prenatal Panel

​​​Trisomy 21, Trisomy 18Trisomy 13Monosomy XTriploidy22q11.2 DeletionChromosome abnormalitiesDown Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome, Klinefelter Syndrome, Triple X Syndrome, Jacob's Syndrome

23152PARASOParaneoplastic Autoantibody Evaluation, Serum (PAVAL)
​​​​AGNA, Amphiphysin Antibody, Serum, ANNA (Antineuronal Nuclear Antibody), Anti-CV2, Anti-Enteric Neuronal Antibody, Anti-Glial Nuclear Antibody, Anti-Hu, Anti-Purkinje Cell Cytoplasmic Antibodies, Anti-Ri, Anti-Yo, Antineuronal, APCA (Anti-Purkinje Cell Antibodies), Calcium Channel Blockers, Cerebellar Antibodies, Cramp-fasciculation, CRMP-5, IgG, Hu Antibody, Myoid Antibody, Neuromyotonia, Neuronal Nuclear Antibody, Neuronal Nuclear Antibody Panel, Neuronal Potassium Channel Ab, Neuronal-Anti, Ovarian Cancer-Related Antibodies, P/Q Type Calcium Channel Antibody, Paraneoplastic Antibodies, Paraneoplastic Autoantibody Evaluation, Paraneoplastic Neurological Autoimmunity, PCA-1 (Purkinje Cell Cytoplasmic Antibodies), PCA-2 (Purkinje Cell Cytoplasmic Antibodies), PCA-Tr (Purkinje Cell Cytoplasmic Antibodies), PCAb (Purkinje Cell Cytoplasmic Antibodies), Potassium Channel Antibodies (specify), Purkinje Cell Cytoplasmic Antibodies, Type 1, Purkinje Cell Cytoplasmic Antibodies, Type 2, Purkinje Cell Cytoplasmic Antibodies, Type Tr, Ri, Anti, VGCC (Voltage-Gated Calcium Channel) Antibodies, VGKC, VGPC, Voltage-Gated Potassium Channel Ab, Yo-Anti, Collapsin Response-Mediator Protein-5 Antibody (CRMP-5), Isaacs Disease, Neuromuscular Hyperexcitability, Purkinje Cell Cytoplasmic Antibodies, Conotoxin Receptor Antibodies
26607PVLESOParaneoplastic Vision Loss Evaluation, Serum (PVLE)

​​​​​​CRMP-5; Anti-CV-2; Recoverin; Retinopathy; Ophthalmitis; Anti-CAR; CAR​

26467PAC1SOParaneoplastic, Autoantibody Evaluation, Spinal Fluid (PAC1)

​Amphiphysin Ab, CSF, ANNA-1, CSF, ANNA-2, CSF, ANNA-3, CSF, Anti-Hu, Antineuronal Cerebellar Antibodies, CRMP-5-IgG, CSF, Dorsal Root Ganglion Antibody, Hu Antibody, Neuron Restricted Autoantibodies, Neuronal Nuclear Antibody, Neuronal-Anti, Ovarian Cancer-Related Antibodies, Paraneoplastic Autoantibody Western Blot Confirmation, CSF, Paraneoplastic Neurological Autoimmunity, PCA-1, CSF, PCA-2, CSF, PCA-Tr, CSF, Purkinje Cell Cytoplasmic Antibodies, Ri, Anti, Yo-Anti

23103IOPTHParathyroid Hormone, Intraoperative Rapid
Parathyroid Surgery Only, IOPTH​
25487MISCParechovirus PCR, CSF
​Entero-Parechovirus, HPeV, Enterovirus
26014PPAPSOParental Prenatal Array Prep Test (PPAP)
26618MISCParoxysmal Nocturnal Hemoglobinuria, PI-Linked Antigen, Blood (PLINK)

​​​Acid Hemolysin; CD55; CD59; FLAER; GPI-Linked Antigen; Ham-Crosby Sugar-Water Test, Blood; Hemolytic Anemia; Paroxysmal Nocturnal Hemoglobinuria (PNH); PI Linked Antigen; Sucrose Analysis; Sucrose Fragility; Sucrose Hemolysis; Sugar Water PNH Screen; Sugar Water Test, Ham-Crosby, Blood

26352FPRTFSOParrot Australian (Budgerigar) Feathers IgE (FPRTF)

​Animal Allergen

Australian (Budgerigar)

Quaker

22759APTTPartial Thromboplastin Time - APTT/PTT
​PTT, APTT, Activated Partial Thromboplastin Time​
22758PTTLAPartial Thromboplastin Time - Lupus Anticoagulant (PTTLA)
PTT-LA, Lupus Anticoagulant PTT,  APTT-LA, StaClot LA​
26116PARVSSOParvovirus B19 Antibodies, IgG and IgM, Serum (PARVS)

B19, Erythrovirus B19, Fifth Disease, Human Parvovirus, Slapped Cheek disease

Parvovirus B19 IgG & IgM Antibodies with Interpretation
23392MISCParvovirus B19, Molecular Detection, PCR, Varies (PARVO)
​​B19, Erythrovirus B19, Fifth Disease-Parvovirus, Human Parvovirus B19, Parvovirus B19 PCR, Parvovirus PCR, Parvovirus-Fifth Disease
26054PARVPSOParvovirus B19, PCR, Plasma (PARVP)
B19, Erythrovirus B19, Fifth Disease-Parvovirus, Human Parvovirus B19, Parvovirus B19 PCR, Parvovirus PCR, Parvovirus-Fifth Disease
26406PDGFSOPDGFB (22q13), Dermatofibrosarcoma Protuberans/Giant Cell Fibroblastoma, FISH, Tissue (PDGF)

COL1A1-PDGFB

COL1A1/PDGFB

DFSP/GCF

t(17;22)​

This test does not include a pathology consultation. If a pathology consultation is requested, PATHC / Pathology Consultation should be ordered and the appropriate FISH test will be ordered and performed at an additional charge.

This test includes a charge for application of the first probe set (2 FISH probes) and professional interpretation of results.

Additional charges will be incurred for all reflex probes performed. Analysis charges will be incurred based on the number of cells analyzed per probe set. If no cells are available for analysis, no analysis charges will be incurred.

25648MISCTISPD-L1 28-8 FDA (OPDIVO/Nivolumab)   
PD-L1, PDL1, 28-8 FDA, CHECKMATE, OPDIVO
25649MISCTISPD-L1, SP142 FDA (TECENTRIQ/atezolizumab) IHC 
PD-L1, PDL1, SP142, TECENTRIQ, ATEZOLIAUMAB, IHC, Immunohistochemistry
22762HD-PDFPeritoneal Equilibration Test
Hemodialysis PDF, Glu/Creat/UreaN​
Glucose, Creatinine, and Urea Nitrogen​
22763MISCPeroxidase Stain
Myeloperoxidase​
26288APHpH, Arterial

​blood pH, arterial pH

​pH

22765PH-BFpH, Body Fluid
22767PH-UpH, Urine Qualitative
26289VPHpH, Venous

​​blood pH, venous pH

​pH

22769PHENOPhenobarbital
Phenobarb​
26097PKUSOPhenylalanine and Tyrosine, Plasma (PKU)

Phenylalanine Includes Tyrosine
PKU (Phenylketonuria)
Tyrosine
Tyrosinemia
Hyperphenylalaninemia

Phenylalanine and Tyrosine
22772PTNPhenytoin
Dilantin, DPH, Diphenylhydantoin​
26603PNYFSOPhenytoin, Free, Serum (PNYF)

Dilantin Free, Serum
Free Dilantin
Free Dilantin, Serum
Free Phenytoin
Dilantin, Total and Free (ORDER PNTFT) ​​

​Phenytoin, Free

26253BLPATCHPhlebotomy Draw - Blood Patch

​Patch

26573PETHCSOPhosphatidylethanol Confirmation, Blood (PETH)

1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphoethanol (PLPEth)

1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol (POPEth)​

25221PSIGMPhosphatidylserine IgM
26576PLA2ISOPhospholipase A2 Receptor, Immunofluorescence, Serum (PLA2I)

Anti-PLA2R; PLA2R​

26588PLA2MSOPhospholipase A2 Receptor, Monitoring, Enzyme-Linked Immunosorbent Assay, Serum

Anti-PLA2R; PLA2R​

22776PHOSPhosphorus
PO4, Inorganic Phosphorus, Phos, Phosphate​
22775PHOS-OPhosphorus, Body Fluid
Body Fluid Phosphorus, Phosphorus, Other​
22777PH-24HPhosphorus, Urine 24 Hour
Phosphorus - Urine, 24hr​
22778PHOS-RUPhosphorus, Urine Random
PO4-RU​
22779PINWPinworm
Enterobius vermicularis, Pinworm Paddle​
25240PIPASOPipecolic Acid, Serum (PIPA)

​​Pipecolic Acid, S

22645PLASMAPlasma
FFP, Fresh Frozen Plasma
24744PCPDFSOPlasma Cell Proliferative Disorder FISH, Bone Marrow (PCPDS)
+1q or 1q22, 17p- (17p deletion) or TP53, IGH (14q32) rearrangement, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Plasma Cell Leukemia, t(11;14) - CCND1/IGH, t(14;16) - IGH/MAF, t(14;20) - IGH/MAFB, t(4;14) - FGFR3/IGH
25601PLASFSOPlasma Cell Proliferative FISH, Tissue (PLASF)

17p- (17p deletion) or TP53, IGH (14q32) rearrangement, Monoclonal Gammopathy of Unknown Significance (MGUS), Multiple Myeloma, Plasma Cell Leukemia, t(4;14) - FGFR3/IGH, t(11;14) - CCND1/IGH, t(14;16) - IGH/MAF, t(14;20) - IGH/MAFB, +1q or 1q22

TI PLASFSO

26578PFHGBPlasma Free Hemoglobin

​Plasma, Hemoglobin​

26608PGL3SOPlasma GL-3 (504662)

​Fabrazzyme biomarker, Fabry disease biomarker

25542PLHBBSOPlasma Hemoglobin (PLHBB)
​​Plasma Free Hemoglobin
Plasma Hemoglobin
26254MISCPlasminogen Activator Inhibitor Antigen, Plasma (PAI1)

​PAI-1 Ag

25464PLGSOPlasminogen Activity, Plasma (PSGN)
Plasminogen, Functional, Plasma
22784PLTAGGPlatelet Aggregation
Agonsists tested:  Epinephrine, ADP, Ristocetin, Collagen and Arachidonic Acid​
24917APASOPlatelet Antibody Screen (5543)
​Ref Lab Code: 5543, Anti-Platelet Antibodies
22954PPR-PPSPlatelet Concentrate
SDP, Single Donor Platelet, Apheresis collected platelet​
22955PLTPlatelet Count
Thrombocyte​
22956PFT-EPIPlatelet Function Test
PFA-100, Platelet Function Assay-100
26161PLM6SPlatelet Mapping on TEG6S

​​PLM, PLM6S, Platelet Mapping ADP, Platelet Mapping AA

​HKH-MA, ActFMA, ADP-MA, %INH-ADP, %AGG-ADP, AA-MA, %INH-AA, %AGG-AA

26457PTEMSOPlatelet Transmission Electron Microscopic Study, Whole Blood (PTEM)
24998PMLSOPML/RARA Quantitative, PCR (PMLR)
(15;17)(q22;q12), Acute myeloid leukemia (AML), Acute promyelocytic leukemia (APL), AML (acute myeloid leukemia), AMPL, APL minimum residual disease, PCR, PML/RARA, ABC
25534MISCPML-RARA Translocation, t(15;17) by RT-PCR, Quantitative (2002871)
AMPL' APL, APL MRD, APL Post-consolidation therapy testing, PML-RARA fusion types, A, B, B variant, PML-RARA long, short, variable types, PML-RARA S, L, V forms, PML_RARA fusion types, Quantitative PML, t(15;17)
26455PNRPSOPneumocystis jiroveci, Molecular Detection, PCR, Varies (PNRP)
25060POLIOSOPoliovirus (Types 1, 3) Antibodies, Neutralization (FPOLO)
​​Polio Immune Status Panel, Polio Vaccine Response, Poliovirus
​Polio 1, 3 Titers
26390FPOLESOPollock White (Pollachius virens) IgE (FPOLE)

​Pollachius virens, Pollock White (Pollachius virens) IgE (FPOLE)

26348PVJAKSOPolycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing for Erythrocytosis, Varies (PVJAK)

JAK2 V617F

JAK2 exon 12

Polycythemia Vera

Myeloproliferative Neoplasm (MPN)

​Both DNA and RNA are extracted. The algorithm starts with a highly sensitive DNA-based JAK2 V617F test by allele specific polymerase chain reaction. If the JAK2 V617F result is negative or very low positive (0.06%-0.6%), JAK2 exon 12-15 Sanger sequencing test will be performed on the stored RNA sample. If a JAK2 V617F mutation (>0.6%) is detected, the algorithm stops and no further testing will be performed.

The Sanger sequencing covers JAK2 exons 12 through the first 90% of exon 15, which spans the region containing essentially all mutations reported in myeloproliferative neoplasms. The following algorithms are available in Special Instructions.

22960PBG-QLPorphobilinogen, Qualitative, Random Urine
​​PBG Qual​
26272PBGUSOPorphobilinogen, Quantitative, Random, Urine (PBGU)

​​Acute Intermittent Porphyria (AIP)
Hereditary Coproporphyria (HCP)
PBG (Porphobilinogen)
Variegate Porphyria (VP)

Porphobilinogen Qnt, U (PBGU)

U PBGUSO

22962PEESOPorphyrins Evaluation, Whole Blood (PEE)
​Erythrocyte Porphyrin, Erythropoietic Protoporphyria (EPP), Free Erythrocyte Porphyrin (FEP), Protoporphyrin, Protoporphyrins, Total, Erythrocytes, RBC Porphyrins, Red Blood Cell Porphyrins, X-linked Dominant Protoporpyria (XLDPP or XDP)
23105PORPHUPorphyrins, Quantitative, 24 Hr Urine (PQNU)

Acute Intermittent Porphyria (AIP)
Congenital Erythropoietic Porphyria (CEP)
Coproporphyrin
Hereditary Coproporphyria (HCP)
PBG (Porphobilinogen)
Porphyria Cutanea Tarda (PCT)
Porphyrins, Fractionation, Urine
Uroporphyrin
Variegate Porphyria (VP)

24 PORPHU

25003POSACSOPosaconazole, Serum (POSA)
​​Noxafil (Posaconazole), Posaconazole (Noxafil)
22964KPotassium
K​, i-Stat Potassium
22963K-OPotassium, Other
.K-Other, Body Fluid Potassium​
22965K-24HPotassium, Urine 24 Hour
​ K-24H​
22966K-RUPotassium, Urine Random
Potassium-Rand Ur​
22967PREALBPrealbumin
Thyroxine-binding prealbumin, transthyretin, PAB​
26623AD2ARSOPrecivity AD2, Reflex to Apolipoprotein E, Plasma (AD2AR)

​​​​AB42/40 Ratio; Alzheimer's; ​Amyloid Beta; Amyloid Probability Score2; APOE; Dementia; Mild cognitive impairment; p-tau217; p-tau217 Ratio; Percent p-tau217; %p-tau217; C2N​

​The PrecivityAD2 blood test measures amyloid beta (Abeta) 42/40 ratio and percent tau phosphorylated at threonine-217 (%p-tau217). The results are then combined and used in a proprietary statistical algorithm to calculate the Amyloid Probability Score 2 (APS2). The APS2, Abeta 42/40 ratio and %p-tau217 are reported, however, individual Abeta42, Abeta40, phosphorylated tau217 and non-phosphorylated tau217 concentrations are not reported. For patients who receive a positive PrecivityAD2 test result, additional testing is performed to measure the apolipoprotein E isoforms E2, E3, and E4.

26624C2AD2SOPrecivityAD2, Plasma (C2AD2)

AB42/40 Ratio; Alzheimer's; Amyloid Beta; Amyloid Probability Score2; APOE; Dementia; Mild cognitive impairment; p-tau217; p-tau217 Ratio; Percent p-tau217; %p-tau217; C2N​

​The PrecivityAD2 blood test measures amyloid beta (Abeta) 42/40 ratio and percent tau phosphorylated at threonine-217 (%p-tau217). The results are then combined and used in a proprietary statistical algorithm to calculate the Amyloid Probability Score 2 (APS2). The APS2, Abeta 42/40 ratio and %p-tau217 are reported, however, individual Abeta42, Abeta40, phosphorylated tau217 and non-phosphorylated tau217 concentrations are not reported.

24816PGABSOPregabalin (PGN)
Lyrica®​
22968PGSERPregnancy Test, Stat
​Pregnancy, HCG, Rapid​
22969PGQLPregnancy Test, Urine Qualitative
Rapid Slide Pregnancy Test, HCG, Urine, Qualitative​
25298PREGNSOPregnenolone, Serum (PREGN)

​Pregnenolone

23215AFPADSOPrenatal Aneuploidy Detection, FISH (PADF)

Ambiguous Genitalia
FISH For Prenatal Aneusomy
Trisomy 13 (Patau Syndrome)
Trisomy 18 (Edwards Syndrome)
Trisomy 21 (Down Syndrome)
Turner Syndrome, FISH
XXY, XXX, or XYY
Prenatal aneuploidy

Amnio Aneuploidy FISH SO (PADF)

AF PADSO

 Prenatal Aneuploidy Detection, FISH

This test includes a charge for application of the first probe set (2 FISH probes) and professional interpretation of results.

Additional charges will be incurred for all reflex probes performed. Analysis charges will be incurred based on the number of cells analyzed per probe set. If no cells are available for analysis, no analysis charges will be incurred.

26516PMND1SOPrimary Membranous Nephropathy Diagnostic Cascade, Serum

​​Anti-PLA2R, PLA2R, Anti-THSD7A, Thrombospondin, THSD7​

22972PRIMSOPrimidone (101)
Mysoline®​
22973PROCSOProcainamide and NAPA (PA)
NAPA (N-Acetyl Procainamide), Pronestyl (Procainamide), N-Acetyl Procainamide
25166PCTProcalcitonin, Serum
25679PINPSOProcollagen I Intact N-Terminal, Serum (PINP)

​Procollagen I Intact N-Terminal

22974PROGESProgesterone
P4
23352PROINSOProinsulin, Plasma (PINS)
Proinsulin, P
22975PROLACProlactin
25486FPGD2SOProstaglandin D2 (FD2PG)
​​​PGD2, FD2PG, Prostaglandins, Prostaglandins PGD2
22981PROT-CFProtein C Activity (Functional)
22229Protein C Antigen
26125PCAGSOProtein C Antigen, No Coumadin (PCAG)

​Protein C Immunologic

22983PROT-CMProtein C Antigen, On Coumadin (500534)
​Protein C Antigen, Protein C Antigen / Factor VII ratio
​Test includes Protein C antigen, Factor VII antigen, and Prot C/Factor VII ratio.
26501PEPProtein electrophoresis, Serum (See test code IEPIT: Protein-Immunotyping (PEP,GAM,IT) Panel (IEPIT))
22230Protein S Antigen
22985PROTSIProtein S Antigen (Free), No Coumadin
22986PROT-SMProtein S Antigen, On Coumadin (500530)
​​​Protein S Antigen, Protein S Antigen/Factor VII Antigen Ratio
​Test includes Protein S antigen, Factor VII antigen, and Prot S/Factor VII ratio.
22987TP-OProtein, Body Fluid
Body Fluid Total Protein, TP-O​
22988CSFTPProtein, CSF Fluid
Spinal Fluid Protein​
22989TPProtein, Total
Protein, Total - Blood
22172PROT-U Protein, Urine
​Urine Protein screen, Protein, Urine, Qualitative, Albumin, Urine Qualitative
22990PRO-24HProtein, Urine 24 Hour
​Protein -24Hr Urine
​Urine Protein and Creatinine
25124PRO-6HProtein, Urine 6 Hour
​Protein, Urine, Quantitative, 6 hours, 6 HR
​Urine Protein and Creatinine
22991ORTHOProtein, Urine, Orthostatic Proteinuria
Orthostatic Proteinuria​
Urine Protein and Creatinine​
22992PRO-CRProtein/Creatinine Ratio, Urine
PR/CR, Random Urine Quantitative Protein​
Urine Protein and Creatinine​
23123PR3Proteinase 3 Antibody
Serine Protease 3, PR3 ANCA​
25507GAMPRITProtein-Immunotyping (PEP,GAM,IT) and Beta 2 Microglobulin
​​Gammopathy profile, Monoclonal gammopathy profile, IF-B2 panel, Quantitative immunoglobulins in serum (IgG, IgA and IgM) with serum protein electrophoresis and Beta-2 Microglobulin ​
IgG, IgA, IgM, Protein electrophoresis (Total Protein, Albumin, Alpha-1, Alpha-2, Beta and Gamma fractions), Beta-2 Microglobulin and total serum protein.  Immunotyping may be ordered by interpreter, at an additional charge.​
25508IEPITProtein-Immunotyping (PEP,GAM,IT) Panel
​IF Panel (if Immunotyping is required by interpreter), IEP, Immunoelectrophoresis panel - includes protein electrophoresis, immunoglobulins IgG, IgA and IgM and ​Immunotyping if needed). 
IT Panel
​Protein Electrophoresis (Total Protein, Albumin, Alpha-1, Alpha-2, Beta, and Gamma Globulins), Immunoglobulin IgG, IgA and IgM.  Immunotyping, if required by interpreter (there is an additional charge for Immunotyping).
23001PTGProthrombin Gene Mutation
 PTG 20210, Prothrombin Gene Mutation (PTG), Hypercoagulability, Thrombophilia
23002PTProthrombin Time - INR
​​​​​​​Protime, PT, INR​, CSPT, CS PT, Code Stroke PT, Code Stroke Protime
22643MISCProtoporphyrins, Fractionation, Erythrocytes (PPFE)
​​​​​EPP (Erythropoietic Protoporphyria), Erythropoietic Protoporphyria, Free Protoporphyrin, Zinc Protoporphyrin, X-linked Dominant Protoporphyria (XLDPP or XDP)
23003MISCProtriptyline (110)
Vivactyl®​
23004PSA-FPSA, Free & Total
​Prostate Specific Antigen, Free & Total​
Total Prostate Specific Antigen , Free Prostate Specific Antigen​
23005PSAPSA, Total
Prostate Specific Antigen, Total​
26332PSA-HPSA, Total Hybritech

​​Prostate Specific Antigen, Total Hybritech

24892PCHOTSOPseudocholinesterase, Total (PCHE1)
​Cholinesterase (Pseudo), Total,  Serum Cholinesterase (Pseudochol), Butyrylcholinesterase
25117PTH-OPTH, Intact - Other Fluids
FNA, Fine Needle Aspirate, Parathyroid Hormone, Fluid, Cyst, PTH​
22925INT-PTHPTH, Intact With Calcium
​Intact PTH, I-PTH, CA-PTH with minerals​
Parathyroid Hormone, Calcium​
23274PTHWOCPTH, Intact, Without Calcium
23250PTHRSOPTH-Related Peptide (PTHRP)
​Humoral Hypercalcemia of Malignancy Factor
Parathyroid Related Polypeptide
Parathyroid Related Protein
PRP
PTH Related Peptide
PTHRP, Plasma
PTH Related Protein
Parathyroid Hormone Related Peptide
26424PUPYUSOPurines and Pyrimidines Panel, Urine (PUPYU)

Adenine, Adenosine, Deoxyadenosine, Deoxyguanosine, Deoxyinosine, Guanosine, Hyperuricemias, Hypoxanthine, Inosine, Orotic Acid, Pyrimidine, Succinyladenosine, Thymidine, Uracil, Thymine, Uric Acid, Uridine, Xanthine, S-Sulfocysteine, Adenine phosphoribosyltransferase deficiency, Adenosine deaminase deficiency, Adenosine monophosphate deaminase deficiency, Adenylosuccinate lyase deficiency, AICAr transformylase/imp cyclohydrolase deficiency, Beta-ureidopropionase deficiency, Carbamoyl phosphate synthetase deficiency, Deoxyguanosine kinase deficiency, Dihydropyrimidinase deficiency, Dihydropyrimidine dehydrogenase deficiency, Hyperornithinemia-hyperammonemia-homocitrullinuria, Lesch-Nyhan syndrome, Molybdenum cofactor deficiency, Phosphoribosyl pyrophosphate synthetase deficiency, Primary hyperoxaluria, Purine metabolism disorders, Purine nucleoside phosphorylase deficiency, Pyrimidine metabolism disorders, Secondary hyperuricemia, Sulfite oxidase deficiency, Thymidine phosphorylase deficiency, Uridine monophosphate synthetase deficiency, Xanthine dehydrogenase and xanthine aldehyde oxidase dual deficiency, Xanthine dehydrogenase deficiency, Xanthine dehydrogenase/xanthine aldehyde oxidase/sulfite oxidase combined deficiency

​Uracil, Thymine, Adenine, Hypoxanthine, Xanthine, Orotic, Dihydroorotic Acid, Uric Acid, Deoxythymidine, Deoxyuridine, Thymidine, Uridine, Deoxyadenosine, Deoxyinosine, Deoxyguanosine, Adenosine, Inosine, Guanoasine, 5-Aminoimidazole-4-carboxyamide 1-beta-D-ribofuranoside (AICAR), Succinyladenosine, S-Sulfocysteine, Dihydrouracil, Dihydrothymine, N-carbomoyl-B-alanine, N-carbomoyl-B-aminoisobutyric Acid

22847PYRUVPyruvate in Blood
Pyruvid Acid, Pyruvate in whole blood​
25658PYRSOPyruvic Acid, Blood (PYR)
​ETC, Mitochondrial Electron Transport Chain Defects, Mitochondrial Respiratory Chain Disorders, PC, PDH (Pyruvate Dehydrogenase) Deficiency, PDHC (Pyruvate Dehydrogenase Complex), Pyruvate Carboxylase Deficiency, Pyruvate Decarboxylase Deficiency, Pyruvate Dehydrogenase (PDH) Deficiency, Pyruvate Dehydrogenase Complex (PDHC), blood pyruvate
25603PYRCSOPyruvic Acid, CSF (PYRC)

​ETC; Mitochondrial Electron Transport Chain Defects; Mitochondrial Respiratory Chain Disorders; PC; PDH (Pyruvate Dehydrogenase) Deficiency; PDHC (Pyruvate Dehydrogenase Complex); Pyruvate; Pyruvate Carboxylase Deficiency; Pyruvate Dehydrogenase (PDH) Deficiency; Pyruvate Dehydrogenase Complex (PDHC); Pyruvate, Spinal Fluid; LP; C PYRCSO

​Pyruvic Acid, CSF